We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.57 | -1.14% | 49.46 | 48.68 | 49.90 | 49.47 | 48.27 | 49.04 | 4,596,609 | 23:02:26 |
From May 2019 to May 2024
By Noemie Bisserbe
PARIS--French drugmaker Sanofi SA said Wednesday it is moving to call a vote on whether to remove the entire board of Medivation Inc. after the U.S. biotech company refused to engage in takeover talks.
Sanofi said it had filed the necessary documents with the U.S. Securities and Exchange Commission and named eight candidates to replace Medivation's board of directors. The move aims to pave the way for shareholders to cast a vote through written consent.
Last month, Medivation Inc. rejected Sanofi's $9.3 billion takeover offer, claiming that the French drugmaker's proposal undervalued the cancer-treatment company.
Write to Noemie Bisserbe at noemie.bisserbe@wsj.com
(END) Dow Jones Newswires
May 25, 2016 08:20 ET (12:20 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
